Apr 25, 2023 / 01:30PM GMT
James Tran - Bloom Burton & Co. - Moderator
Hello, good morning, everyone. Welcome. I think we're going to have people trickling in as the TSX actually opens, and people file in from there. But I think we should start with this session.
Good morning, everyone, and welcome to the 2023 Bloom Burton & Co. healthcare investor conference. You're joining us in Hall B for company presentations. And we'll have five presentations this morning.
First, this morning -- the first presentation will be given by Medexus Pharma. Joining us is Ken d'Entremont, the CEO. He'll be giving a 25-minute -- or 20 to 25-minute presentation, and it will be followed by five minutes of Q&A. If you do have a question, please hold it until the end. We'll come around with a mic so that everyone can hear the question.
So I'd like to welcome Ken to the stage. Ken, the floor is yours. Thank you.
Ken d'Entremont - Medexus Pharmaceuticals, Inc. - CEO & Director
Thank you, James. I want to thank Bloom Burton for the wonderful opportunity
Medexus Pharmaceuticals Inc at Bloom Burton & Co Healthcare Investor Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot